NCT04582578 is a NA clinical trial of CRT in Heart Failure, sponsored by Anthony Tang.

Who is sponsoring NCT04582578?

NCT04582578 is sponsored by Anthony Tang.

What drugs are being tested in NCT04582578?

Interventions in NCT04582578: CRT.

What condition does NCT04582578 study?

NCT04582578 studies Heart Failure.

Is NCT04582578 still recruiting?

NCT04582578 is currently withdrawn. Last updated 9 November 2023.

Last reviewed 2023-11-09 · How we verify

NCT04582578

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Resynchronization for Ambulatory Heart Failure Trial in Patients With Preserved LV Function

Withdrawn NA Last updated 9 November 2023

What this trial tests

NA trial testing CRT in Heart Failure. Withdrawn.

Timeline

3 November 2021

Primary endpoint
23 February 2023

23 February 2023

Quick facts

Lead sponsor	Anthony Tang
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	3 November 2021
Primary completion	23 February 2023
Estimated completion	23 February 2023
Sites	1 location across Canada

Drugs / interventions tested

Conditions studied

Heart Failure — all drugs for Heart Failure →

Sponsor

Anthony Tang

Who can join

18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial will compare two management strategies for HF patients with preserved LV function in sinus rhythm and LBBB. The control group will be treated with practice guideline optimal medical therapy for HF. The experimental group will be treated with CRT in addition to optimal medical therapy for HF. In addition, the trial will further compare two methods of delivering CRT. One experimental group will receive BiV-CRT, while the second experimental group will receive CS-CRT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Conduction system pacing on track to replace CRT? Review of current evidence and prospects of conduction system pacing.
Moustafa AT, Tang AS, Khan HR. · · 2023 · cited 4× · PMID 37649666 · DOI 10.3389/fcvm.2023.1220709

Verify or expand the search:

Other trials of CRT

Trials testing the same drug.

NCT05912036 — The CORTEX Randomized Control Trial · NA · unknown
NCT05732285 — A Pilot Randomized Controlled Trial: CoINTEGRATE · NA · completed
NCT05854290 — Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans · NA · terminated
NCT04564482 — PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer · NA · recruiting
NCT05669092 — A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status · Phase 3 · unknown

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Anthony Tang trials

Trials by the same sponsor.

NCT05923658 — How Clinicians Manage Their Patients Who May Need Antithrombotic Care · unknown
NCT05118893 — Randomized Ablation-based AF Rhythm-control Versus Rate-control in Patients With HF and High-burden AF Extend · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04582578 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anthony Tang
Last refreshed: 9 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04582578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing